Serum Levels of Interleukin-18 (IL-18), Interleukin-1β (IL-1β), its Soluble Receptor sIL-1RII and C-reactive Protein (CRP) in Patients with Lyme Arthritis

被引：0
|
作者：
A. Pietruczuk
R. Świerzbińska
S. Pancewicz
M. Pietruczuk
T. Hermanowska-Szpakowicz
机构：
[1] Regional Hospital,Dept. of Internal Medicine
[2] Medical University of Białystok,Dept. of Infectious Diseases and Neuroinfections
[3] Regional Hospital,Dept. of Internal Medicine
来源：
Infection | 2006年 / 34卷
关键词：
Doxycycline; Lyme Disease; Borrelia Burgdorferi; Lyme Borreliosis; Joint Tissue;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：158 / 162
页数：4
相关论文
共 50 条
  • [31] Polymorphisms of interleukin (IL)-1α, IL-1β, IL-6, IL-10, and IL-18 and the risk of ovarian cancer
    Bushley, AW
    Ferrell, R
    McDuffie, K
    Terada, KY
    Camey, ME
    Thompson, PJ
    Wilkens, LR
    Tung, KH
    Ness, RB
    Goodman, MT
    GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 672 - 679
  • [32] Molecular cloning of porcine interleukin-1β converting enzyme and differential gene expression of IL-1β converting enzyme, IL-1β, and IL-18 in porcine alveolar macrophages
    Muneta, Y
    Shimoji, Y
    Yokomizo, Y
    Mori, Y
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (11): : 1289 - 1296
  • [33] Modulation of arthritis through overexpression of soluble interleukin-1 receptor accessory protein (sIL-1RAcP): A novel inhibitor of interleukin-1, distinct from IL-1Ra.
    Smeets, RL
    van de Loo, FAJ
    Joosten, LAB
    Arntz, OJ
    Bennink, MB
    Curiel, DT
    Martin, MU
    van den Berg, WB
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S152 - S152
  • [34] Modulation of arthritis through overexpression of soluble interleukin-1 receptor accessory protein (sIL-1RAcP): a novel inhibitor of interleukin-1, distinct from IL-1Ra
    Smeets, RL
    van de Loo, FAJ
    Joosten, LAB
    Arntz, OJ
    Bennink, MB
    Curiel, DT
    Martin, MU
    van den Berg, WB
    INFLAMMATION RESEARCH, 2003, 52 (Suppl 2) : S197 - S199
  • [35] Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy
    Fujita, Takayuki
    Shimizu, Chie
    Fuke, Yoshinobu
    Satomura, Atsushi
    Abe, Masanori
    Kaizu, Kazo
    Matsumoto, Koichi
    Soma, Masayoshi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 92 (03) : E66 - E69
  • [36] Urinary levels of kidney injury molecule-1 (KIM-1) and interleukin-18 (IL-18) in children and adolescents with hyperuricemia
    Kamianowska, Monika
    Kamianowska, Aleksandra
    Wasilewska, Anna
    ADVANCES IN MEDICAL SCIENCES, 2023, 68 (01): : 79 - 85
  • [37] The pattern of interleukin-1 beta (IL-1 beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections
    vanDeuren, M
    vanderVenJongekrijg, J
    Vannier, E
    vanDalen, R
    Pesman, G
    Bartelink, AKM
    Dinarello, CA
    vanderMeer, JWM
    BLOOD, 1997, 90 (03) : 1101 - 1108
  • [38] THE EFFECT OF IMMUNOREGULATORY DRUGS ON INTERLEUKIN-1 (IL-1) ACTIVITY AND PLASMA IRON, FIBRONECTIN (FN), ALBUMIN AND C-REACTIVE PROTEIN (CRP) LEVELS IN ADJUVANT ARTHRITIC RATS
    CONNOLLY, K
    STECHER, VJ
    DANIS, E
    CASIELLO, S
    FEDERATION PROCEEDINGS, 1987, 46 (04) : 1370 - 1370
  • [39] Interleukin-1 receptor antagonist production and IL-18 mRNA as markers for biocompatibility of extracorporeal membranes
    Tuma, E
    Eigler, A
    Toepfer, M
    Olma, M
    Brunner, C
    Endres, S
    Schiffl, H
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 495 - 495
  • [40] Blood Interleukin-18 (IL-18) and IL-18 Binding Protein (IL-18BP) Levels Following Midline Laparotomy: A Prospective Randomized Study of Patients With Benign Disease and Patients With Cancer
    Eskelinen, Maaret
    Selander, Tuomas
    Pulkkinen, Jukka
    Haemaelaeinen, Esa
    Eskelinen, Matti
    ANTICANCER RESEARCH, 2024, 44 (05) : 2039 - 2046
12345